The ConferenceAgenda
Wednesday, January 23, 2013
In-Clinic: Observations from the Bedside
Wednesday, January 23
7:30 am - 5:15 pm
Room: Myrna L. Daniels Auditorium
Clinical Methods: Biologics Delivery
7:35 am - 8:30 am
Moderators: Emerson C. Perin, Warren Sherman
7:35 am
Multimodality Imaging: Enhancing Outcomes with Available Technology
7:45 am
Retrograde Techniques
7:55 am
Fiberoptic-guided Transepicardial Delivery
8:05 am
Surgical Delivery: What Role Can We Expect?
8:15 am
Discussion
Discussants: Henricus J. Duckers, Amit Patel, Amish Raval, Jorge Tuma
Clinical Trial Results
8:30 am - 11:15 am
Acute Injury: STEMI
Moderators: Stephen G. Ellis, Hyo-Soo Kim
8:30 am
Long-term FU of Patients with an AMI Treated with Adipose-Derived Stem Cells
8:40 am
STEM-AMI Trial: cMRI and Other Observations at Three Years
8:50 am
Swiss AMI Study: Long-term Findings
9:00 am
Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction
9:10 am
Cardiac-derived Stem Cells Post-MI: CADUCEUS and the ALLSTAR Program
9:20 am
TIME: CCTRN Study of Bone Marrow-Derived Stem Cells Following STEMI
9:30 am
AMR-001 Phase 1 Outcome and PreSERVE Study Design: Autologous CD34+ Cells
9:40 am
Early and Next Phase Studies
Discussants: Henricus J. Duckers, Frank J. Giordano, David F. Kong, Emerson C. Perin, Jerome Roncalli
10:15 am
Predictive Modeling: Identifying Appropriate Endpoint Assessments
10:30 am
Discussion
Poster Session and Break
Industry Panel I. Cell Delivery and Acute Repair Technologies
11:15 am - 12:15 pm
Discussants: Peter A Altman, Philippe R Henon, Michael Hiles, Linda Marban, Mark Martin, Aymeric Seron, Kirk Seward
Lunch and Posters
12:15 pm - 1:15 pm
Chronic Vascular Insufficiency
1:15 pm - 2:25 pm
Moderators: Douglas W. Losordo, Andreas M. Zeiher
1:15 pm
CD34+ Cells for Refractory Angina: ACT 34 CMI Update and Pivotal Phase
1:25 pm
Adipose-Derived Cells for Chronic Ischemia: The PRECISE Trial
1:35 pm
NOGA-Guided CD133+ Cells from CMI
1:45 pm
BMAC for CLI: Status of a Phase 3 Trial
1:55 pm
Early and Next Phase Studies
Discussants: Todd J. Brinton, Emerson C. Perin, David P. Slovut
2:15 pm
Discussion
Heart Failure and Chronic Myocardial Disease
2:25 pm - 4:10 pm
Moderators: Jozef Bartunek, Leslie Miller
2:25 pm
Update CD133 BMSC in CABG Surgery
2:35 pm
SDF-1: Final Results of a Phase 1 Trial and Status of STOP-HF Study
2:45 pm
MPC's for Ischemic and Nonischemic Heart Failure
2:55 pm
REVIVE: 12-Month Functional Results of Retrograde Bone Marrow-Derived Cells CHF
3:05 pm
CD-34+ Cells for Ischemic Heart Failure
3:15 pm
IMPACT Clinical Trial Program: Findings and Strategic Update
3:25 pm
Early and Next Phase Studies
Discussants: Amit Patel, Warren Sherman
3:40 pm
Discussion
Break
4:10 pm - 4:30 pm
Industry Panel II. Acute and Chronic Repair Biotechnologies
4:30 pm - 5:15 pm
Moderators: Hans F. Dohmann, Warren Sherman
Discussants: Frank Ahmann, George W Cole Jr., Andrea Hunt, Thomas Ichim, Howard Leonhardt, Joseph M Pastore, Sharon Watling
Thursday, January 24, 2013
Stem Cell Proofs: Theory, Observation, and Significance
Thursday, January 24
7:55 am - 5:20 pm
Room: Myrna L. Daniels Auditorium
Special Keynote Lecture
8:00 am - 8:30 am
8:00 am
Molecular Windows: Views on Stem Cell Repair and Regeneration
8:20 am
Questions and Discussion
Tissue Structure: Implications for Functional Repair
8:30 am - 9:40 am
Moderators: Gustav Steinhoff, Gordana Vunjak-Novakovic
8:30 am
Imaging of Mechanical Deformation and Electro Mechanical Activation Following Ischemic Injury
8:40 am
Microvascular Obstruction, Infarct Size, and LV Remodeling
8:50 am
Novel Approach to Engineered Mircrovascular Networks
9:00 am
Nutrient and Extracellular Support: Approaches to Tissue Reconstruction
9:10 am
Organ Specific Scaffolds
9:20 am
Discussion
Discussants: Dolly Holt, Elisa Konofagou, Milica Radisic, Gordana Vunjak-Novakovic, Andreas M. Zeiher
Poster Session and Break
9:40 am - 10:10 am
Bio-Strategies for Tissue Repair: Cellular Agents
10:10 am - 11:30 am
Moderators: Stefanie Dimmeler, Marc S. Penn
10:10 am
Transcriptional Reprogramming of Amniotic Cells into Endothelial Cells for Therapy
10:20 am
Scaled-up Method for Cardiosphere Derivation
10:30 am
Myocardial Microtissue Injection in Chronic Ischemic Disease
10:40 am
Directions in hESCs and Myocardial Disease
10:50 am
Biology and Potential Use of IPSC - Derived Cardiomyocytes
11:00 am
Discussion
Discussants: Steven A.J. Chamuleau, Joseph Gold, Hyo-Soo Kim, Shahin Rafii, Brad Swanson
Bio-Strategies for Tissue Repair: Non-Cellular Agents
11:30 am - 12:30 pm
Moderators: Stephen E. Epstein, Eric Olson
11:30 am
MesP1-Driven Cardiac Differentiation
11:40 am
SDF-1 Related Strategies
11:50 am
Targeting microRNAs: A Novel Option to Treat Cardiovascular Disease
12:00 pm
Micro and Nanoparticles as Controlled Release Systems for Cardiac Regeneration
12:10 pm
Discussion
Discussants: Robert David, Stefanie Dimmeler, Marc S. Penn, Felipe Prosper
Lunch and Posters
12:30 pm - 1:30 pm
Preclinical Studies
1:30 pm - 2:50 pm
Moderators: Gustav Steinhoff, Wojciech Wojakowski
1:30 pm
Porcine Studies Using Allogeneic Cardiosphere-derived Cells
1:40 pm
hESC in Porcine Chronic Injury Model: Functional and Other Outcomes
1:50 pm
Effects of MSCs in a Large Animal Model of Ventricular Tachyarrhythmia
2:00 pm
Adipose Stem Cell Rescue from Cigarette Smoke-Induced Marrow Toxicity
2:10 pm
Genomic Screening for Neovascularization
2:20 pm
Human Brown Fat Stem Cells for the Treatment of Metabolic Syndrome
2:30 pm
Discussion
Oral Abstract Presentations
2:50 pm - 3:50 pm
Moderators: Keith L. March, Felipe Prosper
2:50 pm
Oral Abstract Presentation #1
2:55 pm
Discussion
3:00 pm
Oral Abstract Presentation #2
3:05 pm
Discussion
3:10 pm
Oral Abstract Presentation #3
3:15 pm
Discussion
3:20 pm
Oral Abstract Presentation #4
3:25 pm
Discussion
3:30 pm
Oral Abstract Presentation #5
3:35 pm
Discussion
3:40 pm
Oral Abstract Presentation #6
3:45 pm
Discussion
Posters and Break
3:50 pm - 4:05 pm
Industry Panel III. Acute and Chronic Repair Technologies
4:05 pm - 5:20 pm
Moderators: Alan Lewis, Amit Patel
Discussants: P. Kevin Benoit, Phil Coelho, Robert W. Mays, Kevin Murray, Michael Schuster
5:20 pm
Adjourn
Friday, January 25, 2013
Direction and Implementation in Regenerative Cardiovascular Medicine
Friday, January 25
8:00 am - 12:00 pm
Room: Myrna L. Daniels Auditorium
Patients in Need: Defining and Refining our Approach to Target Populations
8:05 am - 9:35 am
Moderators: Jozef Bartunek, Wojciech Wojakowski
8:05 am
Pathogenesis and Study Design in DCM: Ischemic vs. Non-Ischemic, and does it matter?
8:15 am
Combination Left Ventricular Assist Devices and Stem Cell Approaches
8:25 am
Enhanced Wound Healing Strategies
8:35 am
Chronic Pulmonary Disease
8:45 am
Cerebral Ischemia and Stroke
8:55 am
Diabetes Mellitus
9:05 am
Parkinson's Disease
9:15 am
Discussion
Discussants: David Hess, Ulrich P. Jorde, Leslie Miller, Amit Patel, Marc S. Penn, Karen Segal, Jorge Tuma
Break
9:35 am - 9:50 am
Point of View: Strategic Decisions in Regenerative Therapies
9:50 am - 12:00 pm
Moderators: Marc S. Penn, Warren Sherman
9:50 am
Multicenter Collaboration: Strategy for Preclinical Discovery
10:05 am
NIH Clinical Trial Research Network
10:20 am
Pivotal Study Design and Logistics: The BAMI Study
10:35 am
Corporate Strategies for Multi-application Products
10:50 am
Regenerative Medicine: Current Activities and Perspectives
11:05 am
Stem Cells: The Investment Landscape
11:20 am
Discussion
Discussants: Elmar R Burchardt, Timothy D. Henry, Douglas W. Losordo, Jan D. Wald, Andreas M. Zeiher
11:50 am
